Skip to content

Carotid sinus nerve transection to treatment carotid restenosis after CEA

Carotid sinus nerve transection to treatment carotid restenosis after CEA

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300073652
Enrollment
Unknown
Registered
2023-07-18
Start date
2023-07-18
Completion date
Unknown
Last updated
2023-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Carotid artery stenosis

Interventions

Experimental group:Carotid sinus nerve was severed while carotid endarterectomy was performed
Control group:Only carotid endarterectomy was performed

Sponsors

The Second Affiliated Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
55 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1) 55–80 years old, female or male; 2) Symptomatic carotid stenosis, and non-invasive examination shows that carotid stenosis is = 70% or angiography shows that the stenosis is over 50%; 3) Incomplete occlusion of internal carotid artery; 4) NIHSS score = 4; 5) Inform patients and their families, and provide signed informed consent form.

Exclusion criteria

Exclusion criteria: 1) Have a history of unilateral or bilateral CEA or CAS surgery; 2) Complicated with serious organ system diseases, such as renal failure, heart failure and liver cirrhosis; 3) Patients with severe mental illness; 4) Severe arrhythmia or sinus syndrome.

Design outcomes

Primary

MeasureTime frame
Carotid restenosis rate;

Secondary

MeasureTime frame
Carotid atherosclerosis;

Countries

China

Contacts

Public ContactGuodong Liu

The Second Affiliated Hospital of Chongqing Medical University

304678@hospital.cqmu.edu.cn+86 159 2298 2049

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 9, 2026